Terry W. Schorn

1.5k citations

25 papers · 842 indexed · h-index 14

Cardiology and Cardiovascular Medicine top 5%
- Renin-Angiotensin System Studies 13
Organic Chemistry top 10%
- Synthesis and Biological Evaluation 5
- Synthesis and Catalytic Reactions 2
- Quinazolinone synthesis and applications 2
Endocrinology, Diabetes and Metabolism top 10%
Molecular Biology
- Receptor Mechanisms and Signaling 10
Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods 2
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 4
Urology
- Urinary Bladder and Prostate Research 3

Co-authors: Edward H. Blaine Joshua Boger Peter K. S. Siegl Linda S. Payne Raymond S.L. Chang Bruce I. LaMont E H Ulm Martin Poe
Cited by: Cardiology and Cardiovascular Medicine Organic Chemistry Endocrinology, Diabetes and Metabolism
Journals: Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Hypertension (2 papers)
Partner nations: United States Indonesia China

In The Last Decade

Terry W. Schorn

25 papers receiving 784 citations

Peers

Countries citing papers authored by Terry W. Schorn

Since Specialization

Citations

This map shows the geographic impact of Terry W. Schorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry W. Schorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry W. Schorn more than expected).

Fields of papers citing papers by Terry W. Schorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry W. Schorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry W. Schorn. The network helps show where Terry W. Schorn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Terry W. Schorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terry W. Schorn Line = papers co-authored together Terry W. Schorn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design and synthesis of N-alkylated saccharins as selective α-1a adrenergic receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Despacho del Tesoro y Crédito Nacional,Jill M. Erb,Wayne J. Thompson,Anika Denninger,James P. Guare,Chin-Hsiu Chen,Jeffrey M. Bergman,Joel R. Huff,Theodore P. Broten,Raymond S.L. Chang,Tsing B. Chen,Stacey O’Malley,Terry W. Schorn,Ann L. Scott	1998	8
2	Design and Synthesis of Novel α_1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia Journal of Medicinal Chemistry ·Dhanapalan Nagarathnam,John M. Wetzel,Shou Wu Miao,Mohammad R. Marzabadi,George Chiu,Wai C. Wong,Huinan Tian,James C. Fang,Carlos Forray,Theresa A. Branchek,William E. Heydorn,Raymond S.L. Chang,Theodore P. Broten,Terry W. Schorn,Charles Gluchowski	1998	39
3	In vivo pharmacology of a novel AT selective angiotensin II receptor antagonist, MK-996 American Journal of Hypertension ·Salah D. Kivlighn,Gloria J. Zingaro,Robert A. Gabel,Theodore P. Broten,Terry W. Schorn,L W Schaffer,Elizabeth M. Naylor,Probir Chakravarty,Arthur A. Patchett,William J. Greenlee	1995	10
4	Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Salah D. Kivlighn,William R. Huckle,Gloria J. Zingaro,Ralph A. Rivero,Victor J. Lotti,Raymond S.L. Chang,Terry W. Schorn,Maclean Mwamlangala,Robert G. Johnson,W. J. GREENLEE,al. et	1995	30
5	Quinazolinone Biphenyl Acylsulfonamides: A potent new class of angiotensin-II receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Prasun K. Chakravarty,K. Rozumowicz,Tsing‐Bau Chen,Raymond S.L. Chang,Victor J. Lotti,Gloria J. Zingaro,Terry W. Schorn,Salah D. Kivlighn,杨单璇,Arthur A. Patchett,William J. Greenlee	1994	13
6	Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamide Bioorganic & Medicinal Chemistry Letters ·Linda Chang,Wallace T. Ashton,Mumuy Muhdiah,Elizabeth M. Naylor,Porter Km,Arthur A. Patchett,William J. Greenlee,Robert J. Bendesky,Wida Rifa Septiani,Kristie A. Faust,Paul J. Kling,L W Schaffer,Terry W. Schorn,Gloria J. Zingaro,Raymond S.L. Chang,Victor J. Lotti,Salah D. Kivlighn,Peter K. S. Siegl	1994	6
7	A rapid bioassay for the determination of non-nucleoside HIV-1 reverse transcriptase inhibitor plasma levels Life Sciences ·Julie A. O’Brien,Dražen Ostović,Terry W. Schorn,Steven J. Smith,H John,Peter K. S. Siegl,Mark E. Goldman	1993	6
8	Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor. Drug Metabolism and Disposition ·Suresh K. Balani,Mark E. Goldman,yanmin liu,S Varga,J A O'Brien,Sheri Smith,Timothy Olah,Harri G. Ramjit,Terry W. Schorn,Steven M. Pitzenberger	1993	2
9	Inhibitors of human renin with C-termini derived from amides and esters of .alpha.-mercaptoalkanoic acids Journal of Medicinal Chemistry ·Wallace T. Ashton,Han G Brunner,Richard L. Tolman,Valerian J. P. Jésus,Robert J. Lynch,Terry W. Schorn,Мартель Иван Иванович,Peter K. S. Siegl	1992	11
10	Renin inhibitors containing C-termini derived from mercaptoheterocycles Journal of Medicinal Chemistry ·Wallace T. Ashton,Han G Brunner,Laura C. Meurer,Richard L. Tolman,Valerian J. P. Jésus,Arthur A. Patchett,Robert J. Lynch,Terry W. Schorn,Мартель Иван Иванович,Peter K. S. Siegl	1992	28
11	Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors Journal of Medicinal Chemistry ·Stephen E. de Laszlo,Bruce L. Bush,John Doyle,W. J. GREENLEE,David Hangauer,Thomas A. Halgren,Robert J. Lynch,Terry W. Schorn,Peter K. S. Siegl	1992	41
12	Highly potent, orally active diester macrocyclic human renin inhibitors Journal of Medicinal Chemistry ·Ann E. Weber,Mark Steiner,Philip A. Krieter,Adria Colletti,James R. Tata,Thomas A. Halgren,Richard G. Ball,John Doyle,Terry W. Schorn	1992	31
13	Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics Journal of Medicinal Chemistry ·Peter D. Williams,Debra S. Perlow,Linda S. Payne,M. K. HOLLOWAY,Peter K. S. Siegl,Terry W. Schorn,Robert J. Lynch,John Doyle,Мартель Иван Иванович	1991	31
14	Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists Journal of Medicinal Chemistry ·Nathan B. Mantlo,Prasun K. Chakravarty,Debra L. Ondeyka,Peter K. S. Siegl,Raymond S.L. Chang,Victor J. Lotti,Kristie A. Faust,Terry W. Schorn,Selene Margarita Vázquez Soto	1991	135
15	Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys American Journal of Physiology-Renal Physiology ·Raymond E. Gibson,P. Apel,Mark E. Cartwright,丁鎮權,Terry W. Schorn,Patricia B. Bunting,Peter K. S. Siegl	1991	56
16	Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition Journal of Hypertension ·L W Schaffer,Terry W. Schorn,Raymond J. Winquist,Мартель Иван Иванович,Parvathi Eswaran,Prasun K. Chakravarty,Sue Mitra,Arie Hariady Arifin,Daniel F. Veber,常树春,Peter K. S. Siegl	1990	11
17	ChemInform Abstract: Renin Inhibitors. Syntheses of Subnanomolar, Competitive, Transition‐State Analogue Inhibitors Containing a Novel Analogue of Statine. Chemischer Informationsdienst ·Joshua Boger,Linda S. Payne,Debra S. Perlow,M Garrouste-Orgeas,Martin Poe,Edward H. Blaine,E H Ulm,Terry W. Schorn,Antonio Jorge Ferreira Knupp,Tai-Yuan Lin,Masao Kawai,D. H. RICH,Daniel F. Veber	1986	8
18	Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statine Journal of Medicinal Chemistry ·Joshua Boger,Linda S. Payne,Debra S. Perlow,M Garrouste-Orgeas,Martin Poe,Edward H. Blaine,E H Ulm,Terry W. Schorn,Bruce I. LaMont	1985	111
19	Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs. Hypertension ·Edward H. Blaine,Terry W. Schorn,Joshua Boger	1984	57
20	An orally active prostaglandin analog with renal vasodilatory activity in the dog. Journal of Pharmacology and Experimental Therapeutics ·Edward H. Blaine,Horace F. Russo,Terry W. Schorn,Ayse Nisa Akgun	1982	6

About Terry W. Schorn

Terry W. Schorn is a scholar working on Cardiology and Cardiovascular Medicine, Urology and Organic Chemistry, having authored 25 papers that have together received 842 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (13 papers), Receptor Mechanisms and Signaling (10 papers), Synthesis and Biological Evaluation (5 papers), Neuropeptides and Animal Physiology (4 papers), Urinary Bladder and Prostate Research (3 papers), Computational Drug Discovery Methods (2 papers), Synthesis and Catalytic Reactions (2 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (319 citations), Organic Chemistry (283 citations) and Endocrinology, Diabetes and Metabolism (149 citations). Terry W. Schorn has collaborated with scholars based in United States, Indonesia and China. Frequent co-authors include Edward H. Blaine, Joshua Boger, Peter K. S. Siegl, Linda S. Payne, Raymond S.L. Chang, Bruce I. LaMont, E H Ulm, Martin Poe, Victor J. Lotti and Prasun K. Chakravarty. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Hypertension, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact